Overview of Latof
| Property | Description |
|---|---|
| Active ingredient | Latanoprost |
| Form | Ophthalmic solution (Eye drops) |
| Pharmacological class | Prostaglandin analog |
| Common use | Reduction of elevated intraocular pressure (IOP) |
| Origin | Synthetic isopropyl ester prodrug |
What Type of Ocular Medicine is Latof?
Latof is a prescription-only medicine that functions as an ocular hypotensive agent, primarily used to reduce elevated pressure inside the eye. The active substance, latanoprost, is classified as a prostaglandin analog and, more specifically, a prostanoid selective FP receptor agonist. This class of medication is clinically recognized for its high efficacy in lowering intraocular pressure, often positioning it as a first-line treatment in long-term pressure management for conditions like open-angle glaucoma.
Latanoprost is frequently employed due to its proven efficacy and simplified once-daily dosing regimen. This medication is a potent agent for lowering intraocular pressure compared to many other traditional medications.
Latanoprost: Composition and Form of the Ophthalmic Solution
The medication is a synthetic compound delivered as a sterile ophthalmic solution (eye drops) for topical ocular administration. The central component is the active ingredient, latanoprost, which is formulated as an isopropyl ester prodrug contained within an aqueous solution vehicle.
This classification as a prodrug is key to its identity: the molecule is inactive upon application but is rapidly converted in the cornea into the biologically potent form, latanoprost acid, facilitating absorption into the eye. Latof, like its originating brand, is generally a single-entity product distinguished by its focused use of latanoprost for patients requiring monotherapy.
General Purpose: How Latof Supports Eye Health
The general purpose of Latof is the sustained and effective reduction of elevated intraocular pressure (IOP), which is the primary strategy for protecting the optic nerve from pressure-induced damage.
This reduction is achieved by enhancing the drainage of the eye's fluid, or aqueous humor. The active form of the drug increases flow through the uveoscleral outflow pathway, a natural drainage system. For instance, it is a typical medication used in the lifelong management protocol for adults diagnosed with ocular hypertension. By increasing fluid outflow, Latof effectively manages the pressure that could otherwise compromise visual function.
Regulatory References
